Rezultati - Vivek Roy

Refine Results
  1. 1
    Safety and Efficacy of <i>nab</i>-Paclitaxel in the Treatment of Patients with Breast Cancer

    Safety and Efficacy of <i>nab</i>-Paclitaxel in the Treatment of Patients with Breast Cancer od Prakash Vishnu, Vivek Roy

    Izdano 2011
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  2. 2
    Beyond Trastuzumab: Small Molecule Tyrosine Kinase Inhibitors in HER-2–Positive Breast Cancer

    Beyond Trastuzumab: Small Molecule Tyrosine Kinase Inhibitors in HER-2–Positive Breast Cancer od Vivek Roy, Edith A. Perez

    Izdano 2009
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  3. 3
    Expression and function of cell adhesion molecules on fetal liver, cord blood and bone marrow hematopoietic progenitors

    Expression and function of cell adhesion molecules on fetal liver, cord blood and bone marrow hematopoietic progenitors od Vivek Roy, Catherine M. Verfaillie

    Izdano 1999
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  4. 4
    Anti-B Cell Maturation Antigen Chimeric Antigen Receptor T Cell Therapy for the Treatment of AL Amyloidosis and Concurrent Relapsed/Refractory Multiple Myeloma: Preliminary Efficacy and Safety

    Anti-B Cell Maturation Antigen Chimeric Antigen Receptor T Cell Therapy for the Treatment of AL Amyloidosis and Concurrent Relapsed/Refractory Multiple Myeloma: Preliminary Efficac... od Saurav Das, Sikander Ailawadhi, Taimur Sher, Vivek Roy, Andre Fernandez, Ricardo Parrondo

    Izdano 2023
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  5. 5
    Phase II trial of weekly nab (nanoparticle albumin-bound)-paclitaxel (nab-paclitaxel) (Abraxane®) in combination with gemcitabine in patients with metastatic breast cancer (N0531)

    Phase II trial of weekly nab (nanoparticle albumin-bound)-paclitaxel (nab-paclitaxel) (Abraxane®) in combination with gemcitabine in patients with metastatic breast cancer (N0531) od Vivek Roy, Betsy LaPlant, Gerald G. Gross, Charles Bane, Frances M. Palmieri

    Izdano 2008
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  6. 6
    Bone Marrow Transplantation for Diamond-Blackfan Anemia

    Bone Marrow Transplantation for Diamond-Blackfan Anemia od Vivek Roy, Waleska S. Pérez, Mary Eapen, Judith Marsh, Marcelo C. Pasquini, Ricardo Pasqüini, Mahmoud M. Mustafa, Christopher Bredeson

    Izdano 2005
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  7. 7
    Allogeneic hematopoietic stem cell transplant overcomes the adverse survival effect of very high risk and unfavorable karyotype in myelofibrosis

    Allogeneic hematopoietic stem cell transplant overcomes the adverse survival effect of very high risk and unfavorable karyotype in myelofibrosis od Ayalew Tefferi, Daniel K. Partain, Jeanne Palmer, James L. Slack, Vivek Roy, William J. Hogan, Mark Litzow, Rhett P. Ketterling, Mrinal M. Patnaik

    Izdano 2018
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  8. 8
    Dinaciclib, a novel CDK inhibitor, demonstrates encouraging single-agent activity in patients with relapsed multiple myeloma

    Dinaciclib, a novel CDK inhibitor, demonstrates encouraging single-agent activity in patients with relapsed multiple myeloma od Shaji Kumar, Betsy LaPlant, Wee Joo Chng, Jeffrey A. Zonder, Natalie S. Callander, Rafaël Fonseca, Briant Fruth, Vivek Roy, Charles Erlichman, A. Keith Stewart

    Izdano 2014
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  9. 9
    Efficacy of Allogeneic Hematopoietic Cell Transplantation in Cutaneous T Cell Lymphoma: Results of a Systematic Review and Meta-Analysis

    Efficacy of Allogeneic Hematopoietic Cell Transplantation in Cutaneous T Cell Lymphoma: Results of a Systematic Review and Meta-Analysis od Madiha Iqbal, Tea Reljic, Ernesto Ayala, Taimur Sher, Hemant S. Murthy, Vivek Roy, James M. Foran, Han W. Tun, Ambuj Kumar, Mohamed A. Kharfan‐Dabaja

    Izdano 2019
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  10. 10
    A phase 2 study of vorinostat in acute myeloid leukemia

    A phase 2 study of vorinostat in acute myeloid leukemia od Élise Schaefer, Arturo Loaiza‐Bonilla, Mark Juckett, John F. DiPersio, Vivek Roy, James L. Slack, Wenting Wu, K. M. Laumann, Igor Espinoza‐Delgado, S. D. Gore

    Izdano 2009
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  11. 11
    Nephrectomy Followed by Interferon Alfa-2b Compared with Interferon Alfa-2b Alone for Metastatic Renal-Cell Cancer

    Nephrectomy Followed by Interferon Alfa-2b Compared with Interferon Alfa-2b Alone for Metastatic Renal-Cell Cancer od Robert C. Flanigan, Sydney E. Salmon, Brent A. Blumenstein, Scott I. Bearman, Vivek Roy, Patrick C. McGrath, J. R. Caton, Nikhil C. Munshi, E. David Crawford

    Izdano 2001
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  12. 12
    Incidence of extramedullary disease in patients with multiple myeloma in the era of novel therapy, and the activity of pomalidomide on extramedullary myeloma

    Incidence of extramedullary disease in patients with multiple myeloma in the era of novel therapy, and the activity of pomalidomide on extramedullary myeloma od Kristen Detweiler Short, S. Vincent Rajkumar, Dirk R. Larson, Francis K. Buadi, Suzanne R. Hayman, Angela Dispenzieri, Morie A. Gertz, Shaji Kumar, Joseph Mıkhael, Vivek Roy, Robert A. Kyle, Martha Q. Lacy

    Izdano 2011
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  13. 13
    A Phase II trial of the oral mTOR inhibitor everolimus in relapsed Hodgkin lymphoma

    A Phase II trial of the oral mTOR inhibitor everolimus in relapsed Hodgkin lymphoma od Patrick B. Johnston, David J. Inwards, Joseph P. Colgan, Betsy LaPlant, Brian Kabat, Thomas M. Habermann, Ivana N. Micallef, Luis F. Porrata, Stephen M. Ansell, Craig B. Reeder, Vivek Roy, Thomas E. Witzig

    Izdano 2010
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  14. 14
    Ixazomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma: long-term follow-up including ixazomib maintenance

    Ixazomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma: long-term follow-up including ixazomib maintenance od Shaji Kumar, Jesús G. Berdeja, Rubén Niesvizky, Sagar Lonial, Jacob P. Laubach, Mehdi Hamadani, A. Keith Stewart, Parameswaran Hari, Vivek Roy, Robert Vescio, Jonathan L. Kaufman, Deborah Berg, Eileen Liao, S. Vincent Rajkumar, Paul G. Richardson

    Izdano 2019
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  15. 15
    A phase III randomized trial of thalidomide plus zoledronic acid versus zoledronic acid alone in patients with asymptomatic multiple myeloma

    A phase III randomized trial of thalidomide plus zoledronic acid versus zoledronic acid alone in patients with asymptomatic multiple myeloma od Thomas E. Witzig, Kristina Laumann, Martha Q. Lacy, Suzanne R. Hayman, Angela Dispenzieri, Shaji Kumar, Craig B. Reeder, Vivek Roy, John A. Lust, Morie A. Gertz, Philip R. Greipp, Hani Hassoun, Sumithra J. Mandrekar, S. Vincent Rajkumar

    Izdano 2012
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  16. 16
    <i>Cytokeratin-19</i> and <i>Mammaglobin</i> Gene Expression in Circulating Tumor Cells from Metastatic Breast Cancer Patients Enrolled in North Central Cancer Treatment Group Trials, N0234/336/436/437

    <i>Cytokeratin-19</i> and <i>Mammaglobin</i> Gene Expression in Circulating Tumor Cells from Metastatic Breast Cancer Patients Enrolled in North Central Cancer Treatment Group Tria... od Monica M. Reinholz, Kathleen Kitzmann, Kathleen Tenner, David W. Hillman, Amylou C. Dueck, Timothy J. Hobday, Donald W. Northfelt, Alvaro Moreno‐Aspitia, Vivek Roy, Betsy LaPlant, Jake Allred, Philip J. Stella, Wilma L. Lingle, Edith A. Perez

    Izdano 2011
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  17. 17
    Trends in multiple myeloma presentation, management, cost of care, and outcomes in the Medicare population: A comprehensive look at racial disparities

    Trends in multiple myeloma presentation, management, cost of care, and outcomes in the Medicare population: A comprehensive look at racial disparities od Sikander Ailawadhi, Ryan D. Frank, Mayank Sharma, Richa Menghani, M’hamed Temkit, Shumail M. Paulus, Nandita Khera, Shahrukh K. Hashmi, Pooja Advani, Abhisek Swaika, Aneel Paulus, Nabeel Aslam, Taimur Sher, Vivek Roy, Gerardo Colón‐Otero, Asher Chanan‐Khan

    Izdano 2018
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  18. 18
    Trends in the risk of second primary malignancies among survivors of chronic lymphocytic leukemia

    Trends in the risk of second primary malignancies among survivors of chronic lymphocytic leukemia od Vivek Kumar, Sikander Ailawadhi, Leyla Bojanini, Aditya Mehta, Suman Biswas, Taimur Sher, Vivek Roy, Prakash Vishnu, Julian A. Marin‐Acevedo, Victoria R. Alegria, Aneel Paulus, Sonikpreet Aulakh, Madiha Iqbal, Rami Manochakian, Winston Tan, Asher Chanan‐Khan, Meghna Ailawadhi

    Izdano 2019
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  19. 19
    Comparison of reduced intensity conditioning regimens used in patients undergoing hematopoietic stem cell transplantation for myelofibrosis

    Comparison of reduced intensity conditioning regimens used in patients undergoing hematopoietic stem cell transplantation for myelofibrosis od Tania Jain, Katie L. Kunze, M’hamed Temkit, Daniel K. Partain, Mrinal M. Patnaik, James L. Slack, Nandita Khera, William J. Hogan, Vivek Roy, Pierre Noël, José F. Leis, Lisa Z. Sproat, Veena Fauble, Ruben A. Mesa, Jeanne Palmer

    Izdano 2018
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  20. 20
    Unrelated Donor Marrow Transplantation for B-Cell Chronic Lymphocytic Leukemia After Using Myeloablative Conditioning: Results From the Center for International Blood and Marrow Transplant Research

    Unrelated Donor Marrow Transplantation for B-Cell Chronic Lymphocytic Leukemia After Using Myeloablative Conditioning: Results From the Center for International Blood and Marrow Tr... od Steven Z. Pavletic, Issa F. Khouri, Michael Haagenson, Roberta King, Philip J. Bierman, Michael R. Bishop, Michael J. Carston, Sergio Giralt, Arturo Molina, Edward A. Copelan, Olle Ringdén, Vivek Roy, Karen K. Ballen, Douglas R. Adkins, Philip L. McCarthy, Daniel J. Weisdorf, Emili Montserrat, Claudio Anasetti

    Izdano 2005
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:

Iskalna orodja: